XML 85 R74.htm IDEA: XBRL DOCUMENT v3.5.0.2
Condensed Guarantor and Non-Guarantor Financial Statements, Comprehensive Income Statements (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2016
Sep. 30, 2015
Mar. 31, 2015
Sep. 30, 2016
Sep. 30, 2015
CONDENSED CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME          
Net sales $ 320.6 $ 336.4   $ 998.7 $ 1,075.3
Cost of products sold:          
Cost of products sold, excluding depreciation and amortization and other items 254.7 267.3   767.1 864.4
Lower of cost or market inventory write-down 0.0 0.0 $ 4.9 4.9 0.0
Unrealized (gain) loss on derivative instruments (2.0) 1.7   (16.9) 7.7
Depreciation and amortization 9.0 8.1   26.7 24.2
Selling, general, administrative, research and development 25.6 21.1   79.2 67.4
Net periodic postretirement benefit cost relating to Salaried VEBA 0.8 0.6   2.5 1.8
(Gain) loss on removal of Union VEBA net assets 0.0 (2.9)   (0.1) 490.9
Total selling, general, administrative, research and development 26.4 18.8   81.6 560.1
Other operating charges, net 2.7 0.0   2.8 0.0
Total costs and expenses 290.8 295.9   866.2 1,456.4
Operating (loss) income 29.8 40.5   132.5 (381.1)
Other expense:          
Interest expense (5.5) (4.9)   (14.7) (19.9)
Other (expense) income, net 0.0 (0.9)   (10.4) (0.1)
(Loss) income before income taxes 24.3 34.7   107.4 (401.1)
Income tax (provision) benefit (9.4) (12.6)   (40.2) 151.2
Earnings (loss) in equity of subsidiaries 0.0 0.0   0.0 0.0
Net income (loss) 14.9 22.1   67.2 (249.9)
Comprehensive income (loss) 16.0 22.2   70.1 (182.5)
Consolidating Adjustments          
CONDENSED CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME          
Net sales (19.9) (22.5)   (58.8) (73.5)
Cost of products sold:          
Cost of products sold, excluding depreciation and amortization and other items (19.0) (21.1)   (56.3) (70.3)
Lower of cost or market inventory write-down       0.0  
Unrealized (gain) loss on derivative instruments 0.0 0.0   0.0 0.0
Depreciation and amortization 0.0 0.0   0.0 0.0
Selling, general, administrative, research and development (0.6) (0.6)   (2.0) (1.7)
Net periodic postretirement benefit cost relating to Salaried VEBA 0.0 0.0   0.0 0.0
(Gain) loss on removal of Union VEBA net assets   0.0   0.0 0.0
Total selling, general, administrative, research and development (0.6) (0.6)   (2.0) (1.7)
Other operating charges, net 0.0     0.0  
Total costs and expenses (19.6) (21.7)   (58.3) (72.0)
Operating (loss) income (0.3) (0.8)   (0.5) (1.5)
Other expense:          
Interest expense 0.1 0.1   0.1 0.3
Other (expense) income, net (0.1) (0.1)   (0.1) (0.3)
(Loss) income before income taxes (0.3) (0.8)   (0.5) (1.5)
Income tax (provision) benefit 2.5 2.2   11.6 8.5
Earnings (loss) in equity of subsidiaries (22.3) (27.3)   (98.8) 224.7
Net income (loss) (20.1) (25.9)   (87.7) 231.7
Comprehensive income (loss) (21.2) (26.0)   (90.6) 164.3
Parent          
CONDENSED CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME          
Net sales 0.0 0.0   0.0 0.0
Cost of products sold:          
Cost of products sold, excluding depreciation and amortization and other items 0.0 0.0   0.0 0.0
Lower of cost or market inventory write-down       0.0  
Unrealized (gain) loss on derivative instruments 0.0 0.0   0.0 0.0
Depreciation and amortization 0.0 0.0   0.0 0.0
Selling, general, administrative, research and development 0.9 0.9   3.3 3.3
Net periodic postretirement benefit cost relating to Salaried VEBA 0.0 0.0   0.0 0.0
(Gain) loss on removal of Union VEBA net assets   0.0   0.0 0.0
Total selling, general, administrative, research and development 0.9 0.9   3.3 3.3
Other operating charges, net 0.0     0.0  
Total costs and expenses 0.9 0.9   3.3 3.3
Operating (loss) income (0.9) (0.9)   (3.3) (3.3)
Other expense:          
Interest expense (5.7) (4.7)   (15.9) (19.1)
Other (expense) income, net (0.1) (0.6)   (11.1) (0.6)
(Loss) income before income taxes (6.7) (6.2)   (30.3) (23.0)
Income tax (provision) benefit 0.0 0.0   0.0 0.0
Earnings (loss) in equity of subsidiaries 21.6 28.3   97.5 (226.9)
Net income (loss) 14.9 22.1   67.2 (249.9)
Comprehensive income (loss) 16.0 22.2   70.1 (182.5)
Guarantor Subsidiaries          
CONDENSED CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME          
Net sales 313.9 329.5   976.9 1,051.2
Cost of products sold:          
Cost of products sold, excluding depreciation and amortization and other items 250.0 263.1   753.1 848.9
Lower of cost or market inventory write-down       4.9  
Unrealized (gain) loss on derivative instruments (2.0) 1.7   (16.9) 7.7
Depreciation and amortization 8.5 7.8   25.2 23.3
Selling, general, administrative, research and development 24.0 18.4   71.4 58.6
Net periodic postretirement benefit cost relating to Salaried VEBA 0.8 0.6   2.5 1.8
(Gain) loss on removal of Union VEBA net assets   (2.9)   (0.1) 490.9
Total selling, general, administrative, research and development 24.8 16.1   73.8 551.3
Other operating charges, net 2.7     2.8  
Total costs and expenses 284.0 288.7   842.9 1,431.2
Operating (loss) income 29.9 40.8   134.0 (380.0)
Other expense:          
Interest expense 0.1 (0.3)   1.1 (1.1)
Other (expense) income, net 0.1 2.2   0.6 3.0
(Loss) income before income taxes 30.1 42.7   135.7 (378.1)
Income tax (provision) benefit (11.6) (15.6)   (51.1) 140.5
Earnings (loss) in equity of subsidiaries 0.7 (1.0)   1.3 2.2
Net income (loss) 19.2 26.1   85.9 (235.4)
Comprehensive income (loss) 20.3 26.5   88.7 (167.8)
Non-Guarantor Subsidiaries          
CONDENSED CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME          
Net sales 26.6 29.4   80.6 97.6
Cost of products sold:          
Cost of products sold, excluding depreciation and amortization and other items 23.7 25.3   70.3 85.8
Lower of cost or market inventory write-down       0.0  
Unrealized (gain) loss on derivative instruments 0.0 0.0   0.0 0.0
Depreciation and amortization 0.5 0.3   1.5 0.9
Selling, general, administrative, research and development 1.3 2.4   6.5 7.2
Net periodic postretirement benefit cost relating to Salaried VEBA 0.0 0.0   0.0 0.0
(Gain) loss on removal of Union VEBA net assets   0.0   0.0 0.0
Total selling, general, administrative, research and development 1.3 2.4   6.5 7.2
Other operating charges, net 0.0     0.0  
Total costs and expenses 25.5 28.0   78.3 93.9
Operating (loss) income 1.1 1.4   2.3 3.7
Other expense:          
Interest expense 0.0 0.0   0.0 0.0
Other (expense) income, net 0.1 (2.4)   0.2 (2.2)
(Loss) income before income taxes 1.2 (1.0)   2.5 1.5
Income tax (provision) benefit (0.3) 0.8   (0.7) 2.2
Earnings (loss) in equity of subsidiaries 0.0 0.0   0.0 0.0
Net income (loss) 0.9 (0.2)   1.8 3.7
Comprehensive income (loss) $ 0.9 $ (0.5)   $ 1.9 $ 3.5